Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
Small molecule inhibitors target the tissue transglutaminase and fibronectin interaction.
Yakubov B, Chen L, Belkin AM, Zhang S, Chelladurai B, Zhang ZY, Matei D.
PLoS One. 2014 Feb 20;9(2):e89285. doi: 10.1371/journal.pone.0089285. eCollection 2014.
Similar articles
Extracellular tissue transglutaminase activates noncanonical NF-κB signaling and promotes metastasis in ovarian cancer.
Yakubov B, Chelladurai B, Schmitt J, Emerson R, Turchi JJ, Matei D.
Neoplasia. 2013 Jun;15(6):609-19.
Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer.
Shao M, Hollar S, Chambliss D, Schmitt J, Emerson R, Chelladurai B, Perkins S, Ivan M, Matei D.
Mol Cancer Ther. 2012 Jul;11(7):1576-86. doi: 10.1158/1535-7163.MCT-11-0961. Epub 2012 Jun 13.
Targeting ovarian tumor cell adhesion mediated by tissue transglutaminase.
Khanna M, Chelladurai B, Gavini A, Li L, Shao M, Courtney D, Turchi JJ, Matei D, Meroueh S.
Mol Cancer Ther. 2011 Apr;10(4):626-36. doi: 10.1158/1535-7163.MCT-10-0912. Epub 2011 Feb 17.
PDGF induced microRNA alterations in cancer cells.
Shao M, Rossi S, Chelladurai B, Shimizu M, Ntukogu O, Ivan M, Calin GA, Matei D.
Nucleic Acids Res. 2011 May;39(10):4035-47. doi: 10.1093/nar/gkq1305. Epub 2011 Jan 25.
Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase.
Shao M, Cao L, Shen C, Satpathy M, Chelladurai B, Bigsby RM, Nakshatri H, Matei D.
Cancer Res. 2009 Dec 15;69(24):9192-201. doi: 10.1158/0008-5472.CAN-09-1257.
Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor.
Basile DP, Fredrich K, Chelladurai B, Leonard EC, Parrish AR.
Am J Physiol Renal Physiol. 2008 Apr;294(4):F928-36. doi: 10.1152/ajprenal.00596.2007. Epub 2008 Feb 13.
Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage.
Reiners JJ Jr, Caruso JA, Mathieu P, Chelladurai B, Yin XM, Kessel D.
Cell Death Differ. 2002 Sep;9(9):934-44.
Sensitivity of myelomonocytic leukemia cells to arsenite-induced cell cycle disruption, apoptosis, and enhanced differentiation is dependent on the inter-relationship between arsenic concentration, duration of treatment, and cell cycle phase.
McCabe MJ Jr, Singh KP, Reddy SA, Chelladurai B, Pounds JG, Reiners JJ Jr, States JC.
J Pharmacol Exp Ther. 2000 Nov;295(2):724-33.
Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.
Al-Katib AM, Smith MR, Kamanda WS, Pettit GR, Hamdan M, Mohamed AN, Chelladurai B, Mohammad RM.
Clin Cancer Res. 1998 May;4(5):1305-14.
Structural characterization of a ribonuclease III processing signal.
Schweisguth DC, Chelladurai BS, Nicholson AW, Moore PB.
Nucleic Acids Res. 1994 Feb 25;22(4):604-12.
Mutational analysis of a ribonuclease III processing signal.
Chelladurai B, Li H, Zhang K, Nicholson AW.
Biochemistry. 1993 Jul 27;32(29):7549-58.
Ribonuclease III cleavage of a bacteriophage T7 processing signal. Divalent cation specificity, and specific anion effects.
Li HL, Chelladurai BS, Zhang K, Nicholson AW.
Nucleic Acids Res. 1993 Apr 25;21(8):1919-25.
A conserved sequence element in ribonuclease III processing signals is not required for accurate in vitro enzymatic cleavage.
Chelladurai BS, Li H, Nicholson AW.
Nucleic Acids Res. 1991 Apr 25;19(8):1759-66.
Filters: Manage Filters